Prevalence of narcolepsy symptomatology and diagnosis in the European general population.
about
Unmet needs of patients with narcolepsy: perspectives on emerging treatment optionsHistory of narcolepsy at Stanford University.Near-death experience: arising from the borderlands of consciousness in crisis.Narcolepsy and predictors of positive MSLTs in the Wisconsin Sleep Cohort.Incidence, worsening and risk factors of daytime sleepiness in a population-based 5-year longitudinal study.Restless legs syndrome is frequent in narcolepsy with cataplexy patientsCan Functional Magnetic Resonance Imaging Improve Success Rates in CNS Drug Discovery?Lifetime prevalence rates of sleep paralysis: a systematic review.The startle syndromes: physiology and treatment.How to Make the Ghosts in my Bedroom Disappear? Focused-Attention Meditation Combined with Muscle Relaxation (MR Therapy)-A Direct Treatment Intervention for Sleep ParalysisNarcolepsy: current treatment options and future approachesNarcolepsy: a reviewCerebrospinal fluid hypocretin 1 deficiency, overweight, and metabolic dysregulation in patients with narcolepsy.Operational definitions and algorithms for excessive sleepiness in the general population: implications for DSM-5 nosology.Clinical and neurobiological aspects of narcolepsy.CSF hypocretin-1 levels and clinical profiles in narcolepsy and idiopathic CNS hypersomnia in Norway.Sodium oxybate for the treatment of narcolepsy.Predictors of hypocretin (orexin) deficiency in narcolepsy without cataplexyFrequencies and Associations of Narcolepsy-Related Symptoms: A Cross-Sectional Study.Cataplexy associated with narcolepsy: epidemiology, pathophysiology and management.Sodium oxybate for cataplexy.From wakefulness to excessive sleepiness: what we know and still need to know.Comorbidity of Narcolepsy Type 1 With Autoimmune Diseases and Other Immunopathological Disorders: A Case-Control Study.Narcolepsy: immunological aspects.Day case general anaesthesia in a patient with narcolepsy.Urine Toxicology in Adults Evaluated for a Central Hypersomnia and How the Results Modify the Physician's Diagnosis.The impact of gender on timeliness of narcolepsy diagnosisTreatment of narcolepsy.Expert opinion on pharmacotherapy of narcolepsy.Sleepiness that cannot be overcome: narcolepsy and cataplexy.The use of medication against attention deficit/hyperactivity disorder in Denmark: a drug use study from a patient perspective.The diagnosis and treatment of pediatric narcolepsy.Emerging drugs for common conditions of sleepiness: obstructive sleep apnea and narcolepsy.Investigational therapies for the treatment of narcolepsy.Challenges in the development of therapeutics for narcolepsy.Pharmacological management of narcolepsy with and without cataplexy.Treatment Options for Narcolepsy.Management of Narcolepsy.Comparison of Polysomnography and Multiple Sleep Latency Test Findings in Subjects with Narcolepsy and İdiopathic Hypersomnia.Rates and characteristics of sleep paralysis in the general population of Denmark and Egypt.
P2860
Q26827736-E496676D-A1CE-45A6-9B28-91259584F6E4Q30362536-57904150-20CF-4EFA-B117-2D6D36529744Q33164927-83D71E48-D228-44BA-AD10-F5E1D7A6872DQ33587566-56E970EA-A399-4611-B510-0F67A5F4D53AQ33683837-965C36E3-290F-4892-806F-A964BCCACDDEQ33830950-F1276516-399D-4C9C-AA6F-0C12171E6505Q33963735-A1D4F9B2-63B7-4A8C-98FB-923ABE78577DQ34184947-6B34146F-8932-4EC4-8716-2497CD66749EQ34311939-79989E2A-924A-4911-BDD2-C7557F44CC60Q34513087-82E30173-75AD-4069-81F8-302B12C960EAQ34843237-9C7384F7-86D1-417B-9414-22C087BDCE6BQ35212990-DF1D09BE-EBD2-4262-8776-B13F7B50A45DQ35583089-6977FAEE-841D-4FD8-8DF1-7DFF1B7CC01AQ35819334-DA17CC47-3066-4D6E-AA73-13E2501DDD1DQ35995182-838C2BB4-CA8D-40C3-B31D-2D2ED517541CQ35995572-AC09DC4C-C9F2-4E04-9FF9-DDE5F1D4AFC5Q36066116-6980A160-0EAD-469E-8B71-80FCD30F2F6AQ36147074-CFC04DF3-F787-4F97-9062-96B1EEDE0E15Q36323267-436FBF5E-5611-44B5-8ADA-40D2A2B30513Q36361986-2AC2AC91-AF26-4439-B9C8-8B7C13B2A98BQ36409496-04D055AB-C13F-489B-8D7D-49240FEFA672Q36618395-BDA3F10C-AEB5-4730-B450-FF2C5FE7AF71Q36971646-CE9B953D-E54E-4575-87A2-BCF2F70DC960Q37091394-DE9DBD37-F0DB-41D8-B042-F1EC2950FEB4Q37179546-403511DD-F205-4135-BC0F-C08435E2F196Q37363767-44B8667E-A145-41FF-8EE0-3FA1587F999CQ37405862-8113A7FC-30FB-4CD0-9294-2D37E99C8446Q37507989-2BE74B47-18CC-4C15-BC07-7190D165D109Q37738902-EBBDFB38-16E6-486D-9D0A-240A0497EFBBQ37999433-51005BE0-0B96-44C3-AE6F-3760E701B864Q38027452-F20B864F-5140-4CF1-AEC3-C77ABEA784DAQ38222388-35700634-7FDE-4518-8565-B952A0806FF2Q38630470-6ECA8FDC-B9FE-46D0-8BCB-1E8540AAE01EQ38654594-3695E4E9-D905-4C50-B415-DA00DFFB4DFBQ38684472-5564976F-44DE-4563-B6ED-949D97ACB684Q38690847-5C4BBD52-4EA9-488D-883F-85B72DB4DF45Q38828355-71045574-69D7-4A7E-9B91-29EC24B0208CQ38828918-879A3DFD-876C-4C07-A7C9-CED6B91F2327Q38866011-FFA9F516-E214-485A-B94C-CE8133738CADQ39099818-FC3CDD84-575F-4A8C-B983-6F28B1CDA7D5
P2860
Prevalence of narcolepsy symptomatology and diagnosis in the European general population.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Prevalence of narcolepsy symptomatology and diagnosis in the European general population.
@en
Prevalence of narcolepsy symptomatology and diagnosis in the European general population.
@nl
type
label
Prevalence of narcolepsy symptomatology and diagnosis in the European general population.
@en
Prevalence of narcolepsy symptomatology and diagnosis in the European general population.
@nl
prefLabel
Prevalence of narcolepsy symptomatology and diagnosis in the European general population.
@en
Prevalence of narcolepsy symptomatology and diagnosis in the European general population.
@nl
P2093
P356
P1433
P1476
Prevalence of narcolepsy symptomatology and diagnosis in the European general population.
@en
P2093
P304
P356
10.1212/WNL.58.12.1826
P407
P50
P577
2002-06-01T00:00:00Z